Morepen Laboratories reports 16.43 per cent rise in net profit for FY 2019-20 EBIDTA, cash profit (consolidated) for FY 2019-20 also went up by around 9.6 per cent, 10 per cent at Rs 78 crore, Rs 76.02 crore,…
Jubilant Life Sciences – Q4, FY20 results EBITDA was at Rs 1,555 Crore, up 13 per cent YoY with margin at 27.2 per cent, as compared with 25.7 per cent in FY19
